271 related articles for article (PubMed ID: 32848552)
1. Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
Lovelace JW; Ethell IM; Binder DK; Razak KA
Front Neurosci; 2020; 14():771. PubMed ID: 32848552
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice.
Jonak CR; Assad SA; Garcia TA; Sandhu MS; Rumschlag JA; Razak KA; Binder DK
Neurobiol Dis; 2024 Jun; 195():106496. PubMed ID: 38582333
[TBL] [Abstract][Full Text] [Related]
4. Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome.
Razak KA; Binder DK; Ethell IM
Front Psychiatry; 2021; 12():720752. PubMed ID: 34690832
[TBL] [Abstract][Full Text] [Related]
5. Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.
Lovelace JW; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2018 Jul; 115():39-48. PubMed ID: 29605426
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.
Lovelace JW; Rais M; Palacios AR; Shuai XS; Bishay S; Popa O; Pirbhoy PS; Binder DK; Nelson DL; Ethell IM; Razak KA
Cereb Cortex; 2020 Mar; 30(3):969-988. PubMed ID: 31364704
[TBL] [Abstract][Full Text] [Related]
7. Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome.
Jonak CR; Lovelace JW; Ethell IM; Razak KA; Binder DK
Neurobiol Dis; 2020 May; 138():104794. PubMed ID: 32036032
[TBL] [Abstract][Full Text] [Related]
8. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
9. Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome.
Wen TH; Lovelace JW; Ethell IM; Binder DK; Razak KA
Neuroscience; 2019 Feb; 398():126-143. PubMed ID: 30528856
[TBL] [Abstract][Full Text] [Related]
10. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
[TBL] [Abstract][Full Text] [Related]
11. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.
Nguyen AO; Binder DK; Ethell IM; Razak KA
J Neurophysiol; 2020 Jun; 123(6):2101-2121. PubMed ID: 32319849
[TBL] [Abstract][Full Text] [Related]
12. Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice.
Pirbhoy PS; Jonak CR; Syed R; Argueta DA; Perez PA; Wiley MB; Hessamian K; Lovelace JW; Razak KA; DiPatrizio NV; Ethell IM; Binder DK
J Neurodev Disord; 2021 Oct; 13(1):47. PubMed ID: 34645383
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of sound exposure on auditory cortex development in a mouse model of Fragile X Syndrome.
Kulinich AO; Reinhard SM; Rais M; Lovelace JW; Scott V; Binder DK; Razak KA; Ethell IM
Neurobiol Dis; 2020 Feb; 134():104622. PubMed ID: 31698054
[TBL] [Abstract][Full Text] [Related]
14. Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.
Pirbhoy PS; Rais M; Lovelace JW; Woodard W; Razak KA; Binder DK; Ethell IM
J Neurochem; 2020 Dec; 155(5):538-558. PubMed ID: 32374912
[TBL] [Abstract][Full Text] [Related]
15. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome.
Kozono N; Okamura A; Honda S; Matsumoto M; Mihara T
Sci Rep; 2020 Nov; 10(1):18799. PubMed ID: 33139785
[TBL] [Abstract][Full Text] [Related]
16. Sensory Processing Phenotypes in Fragile X Syndrome.
Rais M; Binder DK; Razak KA; Ethell IM
ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
[TBL] [Abstract][Full Text] [Related]
17. Developmental delays in cortical auditory temporal processing in a mouse model of Fragile X syndrome.
Croom K; Rumschlag JA; Erickson MA; Binder DK; Razak KA
J Neurodev Disord; 2023 Jul; 15(1):23. PubMed ID: 37516865
[TBL] [Abstract][Full Text] [Related]
18. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
[TBL] [Abstract][Full Text] [Related]
19. Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
Rotschafer SE; Trujillo MS; Dansie LE; Ethell IM; Razak KA
Brain Res; 2012 Feb; 1439():7-14. PubMed ID: 22265702
[TBL] [Abstract][Full Text] [Related]
20. The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
Jonak CR; Sandhu MS; Assad SA; Barbosa JA; Makhija M; Binder DK
Neurotherapeutics; 2021 Apr; 18(2):1175-1187. PubMed ID: 33594533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
